(PRWeb) February 2, 2007 -- Avanti NanoSciences, located in Baltimore, Maryland, is developing a portfolio of products for rapid, reagent-free detection and removal of endotoxins from biopharmaceutical products. The Maryland bionanotechnology company is engaged in the development of a portfolio of products for the rapid reagent-free detection of microbes, viruses and microbial components based on its advanced, proprietary NanoBindiTM technology.
